Fig. 5From: Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinomaImaging of patient B before and after treatment. A–C MRI findings at the time of recurrence. The red arrows indicate the lesion. D–F Results of MRI re-examination after 12 weeks of combined medication. The red arrow indicates the original lesion site. G–I CT scan at 6 months after liver transplantation. The green arrow indicates the portal vein, the yellow arrow indicates the bile duct, and the blue arrow indicates the inferior vena cavaBack to article page